# Spren

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/spren

- Industry: Medical Devices & Equipment
- Headquarters: Asheville, US
- Website: www.spren.com
- Total disclosed funding: $6M
- Latest round: Seed (Jul 1, 2022)
- Investors on record: 5

## About

Based in North Carolina, US, and founded in 2017 by Jason Moore (CEO), Elite HRV, Inc. doing business as Spren operates as a medical device company that offers a camera-enabled, digital biomarker platform that connects an app to the human body. In October 2022, Spren raised USD 11.3 million in seed funding led by DRIVE by DraftKings, with participation from Boston Seed Capital, Karlani Capital, and Permit Ventures.

Spren's evidence-based machine learning algorithms deliver actionable biomarker insights such as HRV (Heart rate variability), body composition, stress, recovery, progress tracking, and more via an easy-to-integrate SDK (Software Development Kit) and API.

The company plans to use the October 2022 funding to accelerate the expansion of its enterprise biomarker platform.

## Funding rounds

- Seed, Jul 1, 2022, $6M — Boston Seed Capital, Karlani Capital, Amasia, Drive by DraftKings, Permit Ventures

## Investors

- Boston Seed Capital (https://capitalatlas.ai/funds/boston-seed-capital) — Seed
- Karlani Capital (https://capitalatlas.ai/funds/karlani-capital) — Seed
- Amasia (https://capitalatlas.ai/funds/amasia) — Seed
- Drive by DraftKings (https://capitalatlas.ai/funds/drive-by-draftkings) — Seed
- Permit Ventures (https://capitalatlas.ai/funds/permit-ventures) — Seed